Oric Pharmaceuticals ORIC 深 沪
已收盘 09-26 16:00:00 美东时间
11.12
+0.710
+6.82%
华盛通- 最 高11.22
- 今 开10.43
- 成交量 118.75万股
- 最 低 10.37
- 昨 收 10.41
- 总市值 10.80亿
- 52周最高 14.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.8951
- 委 比 -89.32%
- 总股本 9712.30万
- 历史最高 40.81
- 量 比 0.57
- 振 幅 8.17%
- 历史最低 2.36
- 每 手 1
- 风险率 1.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Guggenheim Assumes ORIC Pharmaceuticals at Buy, Announces Price Target of $18
Guggenheim analyst Brad Canino assumes ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $18.
09-04 22:12
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
ORIC Pharmaceuticals任命Kevin Brodbeck博士为首席技术官，以应对即将到来的多期临床试验。Brodbeck博士在制药行业拥有25年经验，曾领导多个关键部门，包括CMC和质量保证。ORIC的临床项目预计将于2026年进入三期试验阶段。Brodbeck博士的加入标志着公司向后期开发迈进的重要一步。
08-18 20:05
INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT
TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, Aug. 15, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is ...
08-15 18:00
Guggenheim Reiterates Buy on ORIC Pharmaceuticals, Maintains $18 Price Target
Guggenheim analyst Michael Schmidt reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and maintains $18 price target.
08-13 21:38
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
ORIC Pharmaceuticals reported promising clinical efficacy and safety data for ORIC-944 in treating metastatic castration-resistant prostate cancer and presented updated financial results. The company strengthened its cash position with $244 million in proceeds from private placement and ATM issuances, enabling a revised operating plan to extend its cash runway into 2H 2028. ORIC prioritized its lead programs, ORIC-944 and enozertinib, and announc...
08-12 20:05
PARAMOUNT AND TKO ANNOUNCE HISTORIC UFC MEDIA RIGHTS AGREEMENT
PARAMOUNT TO BECOME EXCLUSIVE HOME OF UFC IN THE U.S. Beginning in 2026, all UFC numbered events and Fight Nights will stream live on Paramount+, with select marquee fights simulcast on CBS ...
08-11 20:00
美股大行评级 | 潜在涨幅687%！ 花旗上调新氧科技目标价升至5.5美元，评级"买入"
今日重点评级关注：B. Riley证券：维持内克塔治疗"买入"评级，目标价从60美元升至85美元；Oppenheimer：维持Praxis Precision Medicine"跑赢大市"评级，目标价从97美元升至115美元
07-09 09:26
Ladenburg Thalmann Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $15
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $15.
07-09 02:47
新浪财经ESG：ORIC MSCI（明晟）ESG评级调降至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
06-26 07:00
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
06-26 01:30
